Why do cells release vesicles?

Thrombosis Research

Volumn 125, Issue SUPPL. 1, 2010, Pages

  Nieuwland, Rienk ^a   Sturk, Augueste ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Exosome; Microparticle

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AUTOLOGOUS DENDRITIC CELL DERIVED EXOSOME; CANCER VACCINE; DANTRON; MEVINOLIN; P SELECTIN GLYCOPROTEIN LIGAND 1; THROMBOPLASTIN; UNCLASSIFIED DRUG;

CANCER SURVIVAL; CELL COMMUNICATION; CELL PROTECTION; CLINICAL TRIAL; EUKARYOTIC CELL; EXOSOME; HUMAN; HYPERCOAGULABILITY; MELANOMA; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA TRANSPORT; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTIGEN-PRESENTING CELLS; BACTERIA; CELL-DERIVED MICROPARTICLES; DENDRITIC CELLS; DISEASE PROGRESSION; DNA; EXOSOMES; HUMANS; MICROSPHERES; MODELS, GENETIC; NEOPLASMS; SIGNAL TRANSDUCTION; VIRULENCE;

EID: 77949274559     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.01.037     Document Type: Review

References (36)

1. Mashburn L.M., and Whiteley M. Membrane vesicles traffic signals and facilitate groups activities in a prokaryote. Nature 437 (2005) 422-425
2. Kesty N.C., Mason K.M., Reedy M., Miller S.E., and Kuehn M.J. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J 23 (2004) 4538-4549
3. Furuta N., Tsuda K., Omori H., Yoshimori T., Yoshimura F., and Amano A. Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infect Immun 77 (2009) 4187-4196
4. Rodrigues M.L., Nakayasu E.S., Oliveira D.L., Nimrichter L., Nosanchuk J.D., Almeida I.C., et al. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell 7 (2008) 58-67
5. Panepinto J., Komperda K., Frases S., Park Y.D., Djordjevic J.T., Casadevall A., et al. Sec6-dependent sorting of fungal extracellular exosomes and lactase of Cryptococcus neoformans. Mol Microbiol 71 (2009) 1165-1176
6. Kolling G.L., and Matthews K.R. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65 (1999) 1843-1848
7. Yaron S., Kolling G.L., and Matthews K.R. Vesicles-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl Environ Microbiol 66 (2000) 4414-4420
8. del Conde I., Shrimpton C.N., Thiagarajan P., and Lopez J.A. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 (2005) 1604-1611
9. Sims P.J., Faioni E.M., Wiedmer T., and Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263 (1988) 18205-18212
10. de Gassart A., Geminard C., Fevrier B., Raposo G., and Vidal M. Lipid raft-associated protein sorting in exosomes. Blood 102 (2003) 4336-4344
11. Abid-Hussein M.N., Nieuwland R., Hau C.M., Evers L.M., Meesters E.W., and Sturk A. Cell-derived microparticles contain capsase 3 in vitro and in vivo. J Thromb Haemost 3 (2005) 888-896
12. Abid-Hussein M.N., Böing A.N., Sturk A., Hau C.M., and Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 98 (2007) 1096-1107
13. Diamant M., Tushuizen M.E., Abid-Hussein M.N., Hau C.M., Böing A.N., Sturk A., et al. Simvastatin-induced endothelial cell detachment and microparticle release are prnylation dependent. Thromb Haemost 100 (2008) 489-497
14. Valadi H., Edstrom K., Bossios A., Sjostrand M., Lee J.J., and Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007) 654-659
15. Deregibus M.C., Cantluppi V., Calogero R., Lacono M.L., Tetta C., Biancone L., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 111 (2007) 2440-2448
16. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006) 847-856
17. Abusamra A.J., Zhong Z., Zheng X., Li M., Ichim T.E., Chin J.L., et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 35 (2005) 169-173
18. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10 (2008) 619-624
19. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., et al. Glioglastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10 (2008) 1470-1476
20. Shedden K., Xie X.T., Chandaroy P., Chang Y.T., and Rosania G.R. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63 (2003) 433-437
21. Safaei R., Larson B.J., Cheng T.C., Gibson M.A., Otani S., Naerdemann W., and Howell S.B. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 200; 4: 1595-604.
22. Taylor D.D., and Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomerkers of ovarian cancer. Gyn Onc 110 (2008) 13-21
23. Tesselaar M.E., Romijn F.P., Prins F.A., Bertina R.M., and Osanto S. Microparticle-assocaited tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 (2007) 520-527
24. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39 (2003) 184-191
25. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A.M., et al. Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 56 (2009) 479-484
26. Kakkar A.K., DeRuvo N., Chinswangwatanakul V., Tebbutt S., and Williamson R.C. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 346 (1995) 1004-1005
27. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromoboembolic events in malignancy. Clin Cancer Res 15 (2009) 6830-6840
28. Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res in press. doi:10.1016/j.thromres.2009.09.019.
29. Thomas G.M., Panico-Dubois L., Lacroix R., Dignat-George F., Lombardo D., and Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206 (2009) 1913-1927
30. Escudier B., Dorval T., Chaput N., Andre F., Caby M.P., Novault S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 3 (2005) 10-xx
31. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3 (2005) 9-xx
32. Dai S., Wei D., Wu Z., Zhou X., Wei X., Hung H., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16 (2008) 782-790
33. Coleman M.L., Sahai E.A., Yeo M., Bosch M., Dewar A., and Olson M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3 (2001) 339-345
34. Zohrabian V.M., Forzani B., Chau Z., Murali R., and Jhanwar-Uniyal M. Rho/ROCK and MAPK signalling pathways are involved in glioblastoma cell migration and proliferation. Anicancer Res 29 (2009) 119-123
35. Lin C.C., Chen J.T., Yang J.S., Lu H.F., Hsu S.C., Tan T.W., et al. Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9. Oncol Rep 22 (2009) 1033-1037
36. Rattan R., Giri S., Singh A.K., and Singh I. Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res 83 (2006) 243-255